Introduction {#sec1-1}
============

Post-operative total joint patients are at risk for venous thromboembolism (VTE) and pulmonary embolisms (PE), and pharmacologic deep vein thrombosis (DVT) prophylaxis and/or mechanical compression devices have become the standard of care.^[@ref1],[@ref2]^ Postoperative prophylaxis has demonstrated reduced complications associated with deep vein thrombosis (DVT), and the benefits of prophylaxis have been demonstrated post discharge.^[@ref3]^ Patient adherence to DVT prophylaxis has become even more critical given that the Center for Medicare and Medicaid Services (CMS) defines VTEs as never events, and Medicare will not cover the additional costs for managing these complications.^[@ref6]^ To prevent VTEs, surgeons place arthroplasty patients on pharmacologic DVT prophylaxis postoperatively and discharge their patients with instructions to continue taking DVT prophylaxis medication for a total of 10 to 30 days.^[@ref2]^

While most patients are discharged on pharmacologic DVT prophylaxis, surgeons should not assume that their patients are actually taking their medication. There is mounting evidence that a small minority of postoperative patients are not complying with their doctors' orders upon discharge.^[@ref7]^ In the literature, compliance with home DVT prophylaxis for total hip and knee patients ranges from 88-90%.^[@ref10],[@ref11]^ During a quality improvement review of our arthroplasty service, a focus was placed on comparing our patient DVT compliance to the above described studies.

While 100% compliance may not be truly obtainable, it is an aspiration that is in the best interest of our patients. As CMS includes total joint arthroplasty re-admissions as a factor in determining payment reductions, patient compliance with DVT prophylaxis can have a major effect on hospital system fiscal health. The purpose of our study was to evaluate our postoperative THA and TKA patients' DVT prophylaxis compliance and to examine which factors influence compliance. We also wanted to examine the incidence of bleeds as a consequence of DVT prophylaxis. We hypothesize that patients will be more compliant with oral medication than with injectables.

Materials and Methods {#sec1-2}
=====================

This prospective study used an observational, longitudinal design. Between June 2014 and December 2014, patients within the 1 to 3-month post-operative period after a total hip or knee replacement were enrolled in six surgeons' joint replacement clinics. A paper-based survey was administered to patients while they were waiting to be seen in their clinic exam room. Only 20% of eligible patients were enrolled due to staffing/clerical limitations. At the time of this study, each surgeon had an individual preference regarding their patients' DVT prophylaxis medication. Three surgeons preferred patients without risk factors for DVTs receive 325 mg of aspirin twice a day (25 patients), and patients with risk factors for DVTs receive warfarin with an INR goal of 1.8-2.2 (13 patients). Two surgeons preferred to discharge all patients on warfarin, with an INR goal of 1.8-2.2 (52 patients). One surgeon preferred to discharge all patients on prophylactic doses of enoxaparin (7 patients). Four patients had been maintained on Pradaxa (dabigatran) or Xarelto (rivaroxaban) prior to surgery, and these patients were restarted on this regimen on post-operative day two. Each patient received a set of written discharge instructions that explained the importance of DVT prophylaxis. In addition, patients received instruction on the importance of DVT prophylaxis from nursing prior to discharge. Patients also received a list of their prescribed medications. All patients were to maintain prophylaxis for 28 days. Patients discharged on enoxaparin received nursing education on how to self-administer injections. The survey (Appendix) queried for demographic information (age, sex, marital status, occupation), details of the surgery (approach, laterality, discharge location, readmission), DVT prophylaxis management (type of medication, risk for DVTs, deviations from recommended regimen, understanding of regimen), and characteristics of care once they returned home (understanding of discharge instructions, identity and number of caretakers). Nonadherence to DVT prophylaxis was defined as missing at least one dose or deviating from the prescribed dose.

Statistical analysis was performed using SPSS version 21 (SPSS, Inc, Chicago, IL). Chi-square test or Fisher's exact test was used to analyze differences in categorical variables. Missing data was assumed to be missing at random. Unless otherwise stated, all statistical testing was performed with an alpha-level of 0.05.

The study was submitted to and approved by our Institutional Review Board office.

Results {#sec1-3}
=======

Between June 2014 and December 2014, a total of 103 patients completed the questionnaire. The mean age ([Table 1](#table001){ref-type="table"}) of the patients was 67 years, with 43% male and 83% white. Patients who were married or in relationships comprised 57% of the sample, with employed patients making up 36%. Regarding surgical parameters, 50 patients had a total hip replacement and 53 patients had a total knee replacement ([Table 1](#table001){ref-type="table"}). A small percentage of patients stated that they had difficulty understanding discharge instructions ([Figure 1](#fig001){ref-type="fig"}). 21.4% of patients were discharged home without a family member or friend caretaker ([Table 2](#table002){ref-type="table"}).

The most widely used DVT prophylaxis medications after surgery were warfarin (64.4%) and aspirin (24.7%), with enoxaparin (6.9%) and dabigatran/rivaroxaban (4%) less frequently used ([Table 2](#table002){ref-type="table"}). 17.0 % of patients were non-adherent to DVT prophylaxis medications, of which 13.9% missed at least one dose and 3.1% took more medicine than prescribed. Type of medication, route of drug delivery (injection or oral), cost, and occupation (employed/non-employed, manual/nonmanual, full/part time) did not have a statistically significant effect on medication compliance. [Figure 2](#fig002){ref-type="fig"} demonstrates the level of understanding that patients had regarding their DVT prophylaxis instructions. The majority of patients responded that they had a strong understanding of how much medication to take, how long to take the medication, who to call for trouble with medication, risks of not taking the medication, and the reason for taking the medication. However, patients had a lower understanding of the side effects of the medication, with only 47% responding that they had a strong understanding and 16% responding that they were unsure.

In terms of complications, 14.9% of patients required a work-up for a DVT/PE with an ultrasound or CT scan, which was significantly higher in patients who were single (23.8% *vs* 8.6%, P=0.036) ([Table 3](#table003){ref-type="table"}) and in patients who were discharged on warfarin (20.6% *vs* 3.1%, P=0.023) ([Table 4](#table004){ref-type="table"}). The operating surgeon conducted the work-up when patients presented to their clinics with concerning exams. In some cases, these work-ups were led by a medical team upon re-admission to the hospital. No patients suffered draining or a postoperative bleed.

![Patient understanding of discharge instructions. Patient responses regarding their understanding of discharge instructions versus percent of patients. Responses were collected with a 5-point Likert scale (Strong, good, simple, unsure, completely confused).](hr-11-2-7914-g001){#fig001}

![Patient understanding of DVT prophylaxis regimen. Patient responses regarding their understanding of their DVT prophylaxis regimen versus percent of patients. Responses were collected with a 5-point Likert scale (Strong, good, simple, unsure, completely confused).](hr-11-2-7914-g002){#fig002}

###### 

Demographic information and surgical characteristic.

  Variables                     Frequency (N=103)
  ----------------------------- -------------------
  Demographic details           
  Patient age (mean)            67
  Sex                           
      M                         44
      F                         59
  Race                          
      White                     87
      Black                     13
      Asian                     1
      Hispanic                  2
  Marital status                
      Married                   60
      Single                    43
  Occupation                    
      Working                   37
      Not working               66
  Surgical parameters           
  Joint replaced                
      Hip                       50
      Knee                      53
  Side replaced                 
      Unilateral                92
      Bilateral                 11
  Location after discharge      
      Home                      50
      Rehabilitation facility   53

###### 

Patient characteristics that influenced outcomes. Profile of married *vs.* not married patients.

  Variables                                            Frequency
  ---------------------------------------------------- -----------
  Number of people at home available to help (N=103)   
      0                                                22
      1                                                52
      2                                                15
      \>2                                              14
  DVT prophylaxis                                       
      Aspirin                                          25
      Warfarin                                         65
      noxaparin                                        7
      Dabigatran/ rivaroxaban                          4

Discussion {#sec1-4}
==========

Post-operative compliance with DVT prophylaxis is crucial to overall operative success. Maintaining patients on postoperative DVT prophylaxis at home is a challenge, given that many hospitals struggle to maintain inpatients on adequate prophylaxis. ^[@ref12],[@ref13]^ Initiatives undertaken in the hospital setting, such as physician education, use of clinical practice guidelines, use of order sets with VTE prophylaxis options, progress notes with DVT prophylaxis included in a checklist, and electronic alerts to prescribers ^[@ref12],[@ref14]^ have increased physician use of prophylaxis and reduced rates of in hospital DVTs.

Previous studies that have examined TKA and THA patients' home compliance with DVT prophylaxis found 88-90%^[@ref10],[@ref11],[@ref20]^ of patients adhered to their medication regimens. Studies examining the compliance of patients at high risk for DVTs demonstrated similar compliance patterns.^[@ref7],[@ref9]^

Regarding reasons of noncompliance, the literature demonstrates that most patients forget to take 1-2 doses,^[@ref11]^ have difficulty purchasing the medication, lack proper instructions or lack someone available to administer the injection.^[@ref10]^ The literature characterizes patients who are compliant to be younger, employed and with a higher degree of education.^[@ref7],[@ref8],[@ref21]^

In our study, 17.0% of patients were non-adherent to their DVT prophylaxis instructions at some point during their postoperative care. We did not detect any single factor, including type of medication, route of delivery, cost, or patient occupation which affected compliance with DVT medications, and this may be due to our small sample size. None of the noncompliant patients were found to have a DVT. The relationship between patient compliance with medications and actual DVT/PE events should be pursued in a future study. We did find room to improve patient education regarding DVT prophylaxis, as a substantial percentage of patients noted that they had a poor understanding of the side effects of the medication. It is important to educate patients given the potentially serious nature of DVT medication side effects.^[@ref10],[@ref22]^

Compared to those on other DVT prophylaxis medications, we found that patients on warfarin required the most help from their surgeon's office regarding management of the DVT prophylaxis. In addition, warfarin users were much more likely to be worked up for a DVT/PE. Warfarin can be challenging to manage. It has a narrow therapeutic window, requires frequent blood tests and dose-adjustments, and has many drug-drug and diet interactions.^[@ref23]^ It is unclear if these findings were due to the use of warfarin or if this was due to surgeon factors.

In addition, we found that patients who were single were more likely to require a workup for a DVT/PE and had less assistance at home. It is possible that patients discharged home by themselves are less compliant with their DVT prophylaxis, and thus may require a higher level of concern from their surgeon. Another explanation is that these patients are more active, which leads to symptoms that resemble a DVT. None of the patients worked up for a DVT were found to have one.

Limitations of the study include the geographically distinct area and small sample size. Our small sample size may explain why many variables we measured were not found to correlate with adherence or outcomes. In addition, the six surgeons had varying philosophies and biases influencing their anticoagulation prescribing patterns. Because reports of patient compliance relied on patient's memory, the study results are confounded by recall bias. In addition, the number of non-adherences to DVT medications was relatively small. However, the rates found in our study were consistent with those of previous reports.^[@ref11],[@ref20]^

Conclusions {#sec1-5}
===========

This study demonstrates that overall patient compliance with home DVT prophylaxis is high. However, as 17.0% of patients were noncompliant with DVT prophylaxis medication and a percentage of patients noted that they had a poor understanding of the side effects of the medication, our study supports that there is room to improve patient education. As the patient population for total hip and total knee replacement surgeries continues to grow, DVT prophylaxis adherence will be even more important to emphasize. Future studies will focus on the effects of patient education on improving DVT prophylaxis adherence.

###### 

Patient characteristics that influenced outcomes. Profile of married *vs.* not married patients.

  Characteristics        Married         Single          P-value
  ---------------------- --------------- --------------- ----------
  Worked up for DVT/PE   5/58 (8.6%)     10/42 (23.8%)   0.036
  Had helpers at home    56/59 (94.9%)   24/43 (55.8%)   \< 0.001

###### 

Patient characteristics that influenced outcomes. Comparing characteristics in patients prescribed warfarin versus patients prescribed other DVT prophylaxis.

  Characteristics                                                 Warfarin, n (%)   Another DVT prophylaxis, medication   P-value
  --------------------------------------------------------------- ----------------- ------------------------------------- ---------
  Work-up for DVT/PE                                              14/68 (20.6)      1/32 (3.1)                            0.023
  Required help from surgeon's office regarding DVT prophylaxis   56/69 (81.2)      14/32 (43.8)                          \<0.001
  Discharged to rehab facility                                    41/69 (59.4)      10/32 (31.3)                          0.008
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